PRKG1 and diabetic kidney disease: Both upregulation of cGMP–PKG and downregulation of cell senescence signaling pathways can inhibit inflammation, which suggested that OP may improve long-course diabetes nephropathy and diabetes cardiomyopathy by inhibiting inflammation, though through different signaling pathways.